Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.

J Winston, D; G Ho, W; Bartoni, K; Du Mond, C; F Ebeling, D; C Buhles, W; E Champlin, R

doi:10.7326/0003-4819-118-3-199302010-00004

Public

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial.

Shared by NobleBlocks on Feb 1, 1993 • 12:00 AM UTC

Authors:

D J Winston

W G Ho

K Bartoni

Abstract

OBJECTIVE: To evaluate the efficacy and safety of ganciclovir for prevention of cytomegalovirus (CMV) infection and disease. DESIGN: A randomized, placebo-controlled, double-blind trial. SETTING: University-affiliated bone marrow transplant center. PATIENTS: Cytomegalovirus-seropositive allogeneic b...

Discussions